During the medical demo expertise with Xyrem in narcolepsy/cataplexy sufferers at therapeutic doses, two people documented anxiety and just one noted sleeplessness next abrupt discontinuation in the termination with the clinical trial; in the two patients with panic, the frequency of cataplexy experienced elevated markedly at the same time.The Live